0001209191-20-065424.txt : 20201230
0001209191-20-065424.hdr.sgml : 20201230
20201230060012
ACCESSION NUMBER: 0001209191-20-065424
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201229
FILED AS OF DATE: 20201230
DATE AS OF CHANGE: 20201230
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WIGGINS MARK C
CENTRAL INDEX KEY: 0001236540
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36818
FILM NUMBER: 201423970
MAIL ADDRESS:
STREET 1: 12671 HIGH BLUFF DRIVE SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tracon Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001394319
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4350 LA JOLLA VILLAGE DRIVE
STREET 2: SUITE 800
CITY: San Diego
STATE: CA
ZIP: 92122
BUSINESS PHONE: 858-550-0780
MAIL ADDRESS:
STREET 1: 4350 LA JOLLA VILLAGE DRIVE
STREET 2: SUITE 800
CITY: San Diego
STATE: CA
ZIP: 92122
FORMER COMPANY:
FORMER CONFORMED NAME: Tracon Pharmaceuticals Inc
DATE OF NAME CHANGE: 20070324
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-12-29
0
0001394319
Tracon Pharmaceuticals, Inc.
TCON
0001236540
WIGGINS MARK C
C/O TRACON PHARMACEUTICALS, INC.
4350 LA JOLLA VILLAGE DRIVE
SAN DIEGO
CA
92122
0
1
0
0
Chief Business Officer
Common Stock
2020-12-29
4
P
0
997
10.57
A
13697
D
Common Stock
2020-12-29
4
P
0
3
10.56
A
13700
D
Includes 350 shares acquired by the reporting person under the Issuer's 2015 Employee Stock Purchase Plan on October 20, 2020.
/s/ Scott B. Brown, Attorney-in-Fact
2020-12-30